BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 18929550)

  • 1. Inappropriate Off-label Use of a Qualitative, Point-of-care hCG Device.
    Nerenz RD; Gronowski AM; Grenache DG
    West J Emerg Med; 2017 Feb; 18(2):324-325. PubMed ID: 28265335
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimization of Patient Management in the Gynecology Emergency Department Using Point-of-Care Beta hCG.
    Brousse M; Bargnoux AS; Courtais-Coulon C; Badiou S; Kuster N; Compan C; Fuchs F; Cristol JP
    Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-Redox Cation Interaction Improves the Sensitivity of an Electrochemical Immunosensor for Protein Detection.
    Li P; Ge B; Ou LM; Yao Z; Yu HZ
    Sensors (Basel); 2015 Aug; 15(8):20543-56. PubMed ID: 26307986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy and isotretinoin therapy.
    Choi JS; Koren G; Nulman I
    CMAJ; 2013 Mar; 185(5):411-3. PubMed ID: 23296582
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological functions of hCG and hCG-related molecules.
    Cole LA
    Reprod Biol Endocrinol; 2010 Aug; 8():102. PubMed ID: 20735820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on pregnancy testing.
    Fletcher JL
    Prim Care; 1986 Dec; 13(4):667-77. PubMed ID: 3541014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycosylated hCG: a variant with separate biological functions to regular hCG.
    Cole LA; Khanlian SA
    Mol Cell Endocrinol; 2007 Jan; 260-262():228-36. PubMed ID: 17081684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The need for a quantitative urine hCG assay.
    Cole LA; Khanlian SA
    Clin Biochem; 2009 May; 42(7-8):676-83. PubMed ID: 19026624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy.
    Cervinski MA; Lockwood CM; Ferguson AM; Odem RR; Stenman UH; Alfthan H; Grenache DG; Gronowski AM
    Clin Chim Acta; 2009 Aug; 406(1-2):81-5. PubMed ID: 19477170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations in qualitative point of care hCG tests for detecting early pregnancy.
    Greene DN; Schmidt RL; Kamer SM; Grenache DG; Hoke C; Lorey TS
    Clin Chim Acta; 2013 Jan; 415():317-21. PubMed ID: 23159297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the beta-Neocept test for early pregnancy.
    Yuen BH; Pride SM; Callegari PB
    Can Med Assoc J; 1984 Sep; 131(6):583-5. PubMed ID: 6206935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of urinary chorionic gonadotropin in spontaneous abortion of pre-clinically recognized pregnancy: method development and analytical validation.
    Reis MF; Aniceto P; Aguiar P; Simão F; Segurado S
    Int J Hyg Environ Health; 2007 May; 210(3-4):419-27. PubMed ID: 17336148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Background hCG in non-pregnant individuals: need for more sensitive point-of-care and over-the-counter pregnancy tests.
    Cole LA; Ladner DG
    Clin Biochem; 2009 Feb; 42(3):168-75. PubMed ID: 18929550
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.